User profiles for P Dorian

Paul Dorian

Professor of Medicine , University of Toronto
Verified email at unityhealth.to
Cited by 51235

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management

JMO Arnold, P Liu, C Demers, P Dorian… - Canadian Journal of …, 2006 - Elsevier
Heart failure remains a common diagnosis, especially in older individuals. It continues to be
associated with significant morbidity and mortality, but major advances in both diagnosis …

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options—a report from the 3rd Atrial Fibrillation Competence …

…, H Heidbuchel, D Lane, L Mont, S Willems, P Dorian… - Europace, 2012 - academic.oup.com
While management of atrial fibrillation (AF) patients is improved by guideline-conform
application of anticoagulant therapy, rate control, rhythm control, and therapy of accompanying …

2016 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation

…, M Sharma, S Verma, S Connolly, P Dorian… - Canadian Journal of …, 2016 - Elsevier
… that 63.2% of 260 patients randomized to ablation (either pulmonary vein isolation or biatrial
ablation as a secondary randomization) were in sinus rhythm at 1 year vs 29.4% (P < 0.001) …

[HTML][HTML] Rhythm control versus rate control for atrial fibrillation and heart failure

…, M Talajic, S Nattel, DG Wyse, P Dorian… - … England Journal of …, 2008 - Mass Medical Soc
Background It is common practice to restore and maintain sinus rhythm in patients with atrial
fibrillation and heart failure. This approach is based in part on data indicating that atrial …

[HTML][HTML] Amiodarone to prevent recurrence of atrial fibrillation

D Roy, M Talajic, P Dorian, S Connolly… - … England Journal of …, 2000 - Mass Medical Soc
… (63 percent) had a recurrence of atrial fibrillation (P<0.001). Adverse events requiring the …
, as compared with 11 percent of those treated with sotalol or propafenone (P=0.06). …

[HTML][HTML] Atrial fibrillation in patients with cryptogenic stroke

DJ Gladstone, M Spring, P Dorian… - … England Journal of …, 2014 - Mass Medical Soc
Background Atrial fibrillation is a leading preventable cause of recurrent stroke for which
early detection and treatment are critical. However, paroxysmal atrial fibrillation is often …

Canadian Implantable Defibrillator Study (CIDS) a randomized trial of the implantable cardioverter defibrillator against amiodarone

SJ Connolly, M Gent, RS Roberts, P Dorian, D Roy… - Circulation, 2000 - Am Heart Assoc
… reviewed the unblinded study data every 6 months for safety and did 3 formal interim analyses
of efficacy on the basis of an intention to stop the study early in favor of ICD if 1-sided P≤…

[HTML][HTML] Prophylactic use of an implantable cardioverter–defibrillator after acute myocardial infarction

SH Hohnloser, KH Kuck, P Dorian… - … England Journal of …, 2004 - Mass Medical Soc
Background Implantable cardioverter–defibrillator (ICD) therapy has been shown to
improve survival in patients with various heart conditions who are at high risk for ventricular …

[HTML][HTML] Dronedarone in high-risk permanent atrial fibrillation

…, G Di Pasquale, R Diaz, P Dorian… - … England Journal of …, 2011 - Mass Medical Soc
Background Dronedarone restores sinus rhythm and reduces hospitalization or death in
intermittent atrial fibrillation. It also lowers heart rate and blood pressure and has antiadrenergic …

[HTML][HTML] Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation

P Dorian, D Cass, B Schwartz, R Cooper… - … England Journal of …, 2002 - Mass Medical Soc
… with 12.0 percent of 167 patients treated with lidocaine (P=0.009; odds ratio, 2.17; 95
percent … and 15.3 percent of those given lidocaine survived to hospital admission (P=0.05). …